Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
September Broke Heat Records
After a summer of record-breaking heat, scientists say the month of September proved to be far warmer on average than other months.
Load More